• Peter von Dadelszen, J Mark Ansermino, Guy Dumont, G Justus Hofmeyr, Laura A Magee, Matthews Mathai, Diane Sawchuck, Kate Teela, France Donnay, James M Roberts, and PRE-eclampsia-Eclampsia Monitoring, Prevention and Treatment Group.
• Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, Canada. pvd@cw.bc.ca
• Int J Gynaecol Obstet. 2012 Oct 1;119 Suppl 1:S30-4.

AbstractThe hypertensive disorders of pregnancy (HDP; pre-existing hypertension, gestational hypertension, and pre-eclampsia) remain important causes of maternal morbidity and mortality, especially in low- and middle-income countries. The paper summarizes the current state of evidence around possible technologies to support community-based improvements in maternal and perinatal outcomes for women with pre-eclampsia. Through the testing and, where proven, introduction of these technologies, we believe that HDP-related progress toward achieving Millennium Development Goal 5 can best be accelerated. The evidence and discussion are presented under the following headings: (1) prediction; (2) prevention; (3) diagnosis; (4) risk stratification; (5) decision aids; (6) treatment; (7) geographic information systems; (8) communication; and (9) community and patient education.Copyright © 2012 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.

24 keywords...

hide…